Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_assertion evidence source_evidence_literature NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_assertion SIO_000772 24094005 NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_assertion wasDerivedFrom befree-2016 NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_assertion wasGeneratedBy ECO_0000203 NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1116206.RAbPskC6WUK5eAit31AF1pFEnBfuGc9Hgph4DRPQvUbn0130_provenance.